Group One Trading, L.P. Aadi Bioscience, Inc. Transaction History
Group One Trading, L.P.
- $2.54 Billion
- Q4 2024
A detailed history of Group One Trading, L.P. transactions in Aadi Bioscience, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 500 shares of AADI stock, worth $1,285. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500Holding current value
$1,285% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding AADI
# of Institutions
57Shares Held
15.6MCall Options Held
15KPut Options Held
3.1K-
Avoro Capital Advisors LLC New York, NY2.85MShares$7.32 Million0.13% of portfolio
-
Qvt Financial LP New York, NY2.31MShares$5.95 Million0.72% of portfolio
-
Bml Capital Management, LLC Zionsville, IN2.1MShares$5.4 Million4.12% of portfolio
-
Acuta Capital Partners, LLC Belmont, CA1.85MShares$4.75 Million8.31% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.15MShares$2.95 Million1.96% of portfolio
About Aadi Bioscience, Inc.
- Ticker AADI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 21,016,800
- Market Cap $54M
- Description
- Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...